Literature DB >> 12787401

Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF-induced mesangial cell migration.

Kim Hansen1, Christine K Abrass.   

Abstract

BACKGROUND: Laminin (LM), the major glycoprotein component of basement membranes is expressed as multiple isoforms in a developmentally regulated and tissue-specific manner. LM alpha4 has a limited tissue distribution and is highly expressed in the developing glomerulus. In the present study, we investigate the in vivo and in vitro expression and function of LM alpha4 in the glomerulus.
METHODS: LM alpha4 expression was examined by Northern blot, reverse transcription polymerase chain reaction (RT-PCR), Western blot, and immunofluorescence microscopy. Mesangial cells (MC) were plated on purified LM-1, LM-2, and LM-8/9. Immunofluorescence microscopy was performed to examine the cellular phenotypes induced by LM-1 and LM-8/9. A modified Boyden chamber method was used to assess laminin participation in platelet-derived growth factor (PDGF)-stimulated migration.
RESULTS: mRNA for LMalpha4 is expressed in cultured rat MC, and isolated rat and mouse glomeruli, but not in cultured rat glomerular epithelial cells or glomerular endothelial cells. Using antibodies specific for LM alpha4, a 240 kD band was detected in MC extract and a slightly smaller band was identified in extracted rat glomeruli. Purified LM-8/9 had MC adhesive activity comparable to LM-1 and LM-2. MC attached to LM-8/9 exhibited a unique phenotype. In contrast to LM-1, attachment of MC to LM-8/9 produced a highly arborized cell morphology with significantly reduced formation of focal contacts or stress fibers. LM alpha4 is utilized by MC during PDGF-stimulated migration.
CONCLUSION: LM alpha4 is synthesized by MC and persists in the mature glomerulus. LM-8/9 stimulates a unique cellular morphology, and they are utilized in PDGF-induced migration. These factors suggest that LM alpha4 plays an important role in MC differentiation and in the maintenance of MC phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787401     DOI: 10.1046/j.1523-1755.2003.00039.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells.

Authors:  Yan Jiang; Davis W Cheng; Errol D Crook; Lalit P Singh
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

2.  Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.

Authors:  Sujata Lakhe-Reddy; Shenaz Khan; Martha Konieczkowski; George Jarad; Karen L Wu; Louis F Reichardt; Yoshimi Takai; Leslie A Bruggeman; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

3.  Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor.

Authors:  Christine K Abrass; Kim M Hansen; Bruce L Patton
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

4.  Laminin 511 partners with laminin 332 to mediate directional migration of Madin-Darby canine kidney epithelial cells.

Authors:  Patricia G Greciano; Jose V Moyano; Mary M Buschmann; Jun Tang; Yue Lu; Jean Rudnicki; Aki Manninen; Karl S Matlin
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

5.  Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.

Authors:  Duane Delimont; Brianna M Dufek; Daniel T Meehan; Marisa Zallocchi; Michael Anne Gratton; Grady Phillips; Dominic Cosgrove
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

Review 6.  CD146, from a melanoma cell adhesion molecule to a signaling receptor.

Authors:  Zhaoqing Wang; Qingji Xu; Nengwei Zhang; Xuemei Du; Guangzhong Xu; Xiyun Yan
Journal:  Signal Transduct Target Ther       Date:  2020-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.